News

COVID Antibody Treatment Sotrovimab Supplies Running Out in Texas

AUSTIN, Texas – The Texas Department of Health Services is warning that five infusion centers in their area have run out of the only monoclonal antibody treatments known to be effective against the omicron variant. of COVID-19, currently accounts for 90% of new cases. in the state.

The Texas Department of Health Services said its regional infusion centers in Austin, El Paso, Fort Worth, San Antonio and The Woodlands “have exhausted supplies of Sotrovimab,” the monoclonal antibody treatment. Only effective against omicron variation. The department said the scarcity stems from a nationwide shortage of the drug, which is made by GlaxoSmithKline and received an emergency use authorization from the US Food and Drug Administration in May.

Affected infusion centers will not be able to supply Sotrovimab until federal authorities send in additional supplies in January. Chris Van Deusen, a spokesman for the department, said it is likely that other infusion centers will use the rest of their Sotrovimab over the next few days.

Monoclonal antibodies are laboratory-made proteins that mimic the way the immune system stops viruses from entering healthy cells, and they have been used to treat patients at risk of infection. severe illness from COVID-19.

Scarcity of treatments will leave the state health department without a vital tool to fight the virus as cases increase across the country. Several hospitals in the New York area have had to stop offering monoclonal antibody treatments because they ran out of Sotrovimab. The hospitals said they will resume supplies as they receive additional supplies from federal and state agencies.

Van Deusen said Texas bought 1,000 courses of treatment in September, before the federal government bought most of the supply. Between state purchases and allocations from the federal government, Texas received about 12,000 Sotrovimab courses this year.

The department does not know how many additional courses it will receive from the federal government in January, but supply will likely remain constrained because of production constraints, Van Deusen said.

The federal government halted all shipments of monoclonal antibodies late last month while scientists study the effectiveness of the antibodies against omicrons. But in December, the federal government resumed distribution of Sotrovimab, including 55,000 doses believed to have been distributed since early last week, according to NBC News.

A spokesperson for the US Department of Health and Human Services told NBC News that the department expects more than 300,000 doses of the drug next month.

The Texas Tribune is a nonprofit, nonpartisan media organization that informs Texans – and interacts with them – about public policy, politics, government, and statewide issues.

https://abc13.com/covid-treatment-sotrovimab-antibodies-texas/11398744/ COVID Antibody Treatment Sotrovimab Supplies Running Out in Texas

Dais Johnston

USTimeToday is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – admin@ustimetoday.com. The content will be deleted within 24 hours.

Related Articles

Back to top button